Clinical Trial Update: A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tolerability, efficacy, and safety of HSK3486 injectable emulsion in colonoscopy patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Colonoscopy-related Condition

Drugs mentioned

• HSK3486 injectable emulsion (HSK3486)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Colonoscopy | Phase 2 | Status: COMPLETED